Benefit the society, create a better life
Lunan Pharma Group CO., LTD, established in 1968, stands as one of the leading pharmaceutical companies in China. With a commitment to benefiting society and creating a better life, Lunan Pharma has cultivated a well-trained professional marketing team, comprising approximately 9000 sales representatives. This robust marketing capability has propelled Lunan Pharma's total sales to an impressive 1.76 billion dollars.
Shandong New Time Pharma, a subsidiary of Lunan Pharma, has successfully passed FDA inspection, underscoring the company's dedication to quality and regulatory compliance. The group has already submitted 3 ANDAs, including sevoflurane 250ml for inhalation, and plans to submit approximately 8 ANDAs each year moving forward. Lunan Pharma also boasts a strong portfolio of biological products, including insulin glargine, pegfilgrastim, PD-1, and Rituximab biosimilar.
Lunan Pharma Group CO., LTD is dedicated to becoming a large-scale, comprehensive pharmaceutical research and manufacturing base, recognized both domestically and on a global scale. Located at No.209, Hongqi Road, Linyi, Shandong 276006, CN, Lunan Pharma continues to innovate and expand its reach in the pharmaceutical industry. We invite the manager of Lunan Pharma to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's profile.
鲁南制药集团股份有限公司成立于1968年,是中国领先的制药企业之一。鲁南制药致力于造福社会,创造美好生活,拥有一支训练有素的专业营销团队,拥有约9000名销售代表。凭借其独特的营销能力,公司总销售额达17.6亿美元。
鲁南制药的子公司山东新时代药业已成功通过FDA检查,突显了公司对质量和法规的承诺。该集团已提交3个ANDA,包括吸入用七氟醚250ml,并计划今后每年提交约8个ANDA。鲁南制药还拥有一系列强大的生物制品,包括甘精胰岛素、培非格司亭、PD-1和利妥昔单抗生物类似药。
鲁南制药集团股份有限公司致力于成为国内领先、世界一流的大型综合性医药研发生产基地。鲁南制药位于中国山东省临沂市红旗路209号,邮编276006,不断创新并扩大其在制药行业的影响力。我们诚挚邀请鲁南制药的管理者在我们的平台上创建一个定制的、独家的公司展示和产品列表,以进一步提升贵公司的形象。
Other organizations in the same industry
This company is also known as